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Abstract
Background: In the course of infection, viruses such as HIV-1 must enter a cell, travel to sites where they can hijack 
host machinery to transcribe their genes and translate their proteins, assemble, and then leave the cell again, all while 
evading the host immune system. Thus, successful infection depends on the pathogen's ability to manipulate the 
biological pathways and processes of the organism it infects. Interactions between HIV-encoded and human proteins 
provide one means by which HIV-1 can connect into cellular pathways to carry out these survival processes.
Results: We developed and applied a computational approach to predict interactions between HIV and human 
proteins based on structural similarity of 9 HIV-1 proteins to human proteins having known interactions. Using 
functional data from RNAi studies as a filter, we generated over 2000 interaction predictions between HIV proteins and 
406 unique human proteins. Additional filtering based on Gene Ontology cellular component annotation reduced the 
number of predictions to 502 interactions involving 137 human proteins. We find numerous known interactions as well 
as novel interactions showing significant functional relevance based on supporting Gene Ontology and literature 
evidence.
Conclusions: Understanding the interplay between HIV-1 and its human host will help in understanding the viral 
lifecycle and the ways in which this virus is able to manipulate its host. The results shown here provide a potential set of 
interactions that are amenable to further experimental manipulation as well as potential targets for therapeutic 
intervention.
Background
Pathogen invasion and survival requires that the patho-
gen interact with and manipulate its host. Human immu-
nodefficiency virus type 1 (HIV-1) encodes only 15
proteins and must therefore rely on the host cell's
machinery to accomplish vital tasks such as the transport
of viral components through the cell and the transcrip-
tion of viral genes [1,2]. HIV-1 infects human cells by
binding to CD4 and a coreceptor, fusing with the cell
membrane and uncoating the virion core in the cyto-
plasm [2]. The genomic RNA is then reverse transcribed
and the DNA enters the nucleus as part of a viral pre-
integration complex (PIC) containing both viral and host
proteins. Afterwards, the viral DNA is inserted into the
genome by viral integrase (IN) [1]. The integrated provi-
rus is transcribed by host RNA polymerase II from a pro-
moter located in the provirus long terminal repeat (LTR),
and the RNA is exported to the cytoplasm [1,2]. Host
machinery translates HIV-1 mRNA, and several of the
resulting proteins are transported to the cell membrane
to be packaged into the virion along with the genomic
RNA and multiple host proteins. The virus then buds
from the cell and undergoes a maturation process, which
enables it to infect other cells [2]. Throughout this pro-
cess, host proteins play an indispensable role.
To understand the interface through which the patho-
gen connects with and manipulates its host requires
knowledge of the molecular points of interaction
between them. Specifically, knowledge of the protein
interactions between pathogen and host is of particular
value. While the prediction of protein interactions within
species such as S. cerevisiae and H. sapiens has been pur-
sued for some time, it is only recently that host-pathogen
interactions have come under greater scrutiny. Indeed,
computational approaches are of significant value in the
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host-pathogen context as large-scale experimental char-
acterization of these interactions is non-trivial [3-6].
As a result of the need for computational approaches,
several recent methods have been developed and applied
to host-pathogen interactions, suggesting additional
potential interactions in different host-pathogen systems.
For instance, Dyer et al. predicted interactions between P.
falciparum  and human using statistics about domains
involved in within-species interactions [7]. Also focusing
on malaria, Lee and colleagues generated predictions
based on interactions between orthologous proteins from
eukaryotes [8]. In the context of HIV-human interactions,
at least two computational methods have been applied. In
the first study, Tastan et al. used a computational
approach based on the random forest method to predict
protein interactions using features taken from human
proteins and the human interactome [9]. In the second
study, Evans et al. predicted possible interactions using
short sequence motifs conserved in both HIV-1 and
human proteins [10].
While of value, most approaches have not utilized the
significant amount of protein structure information that
is increasingly available. Specifically, rapid progress in
structure determination technologies has led to the
establishment and deposition of massive numbers of pro-
tein structures into the Protein Data Bank, with over
60,000 protein structures currently deposited [11]. In
combination with documented protein-protein interac-
tions, the use of protein structure information provides
another means for the prediction of possible protein
interactions [12-14]. The central premise in such
approaches is that, given a set of proteins with defined
structures and associated interactions, proteins with sim-
ilar structures or substructures will tend to share interac-
tion partners. In the context of host-pathogen
interactions, Davis et al., used homology modeling to
ascertain potential protein interactions for pathogens
responsible for several tropical diseases [15]. Unfortu-
nately, despite their potential value, such computational
structure approaches have not been widely applied to the
problem of predicting host-pathogen interactions.
Here, we develop a map of interactions between HIV-1
and human proteins based on protein structural similar-
ity. In this approach, we first retrieve structural similarity
between host and pathogen proteins identified by an
established method which compares known crystal struc-
tures. Human proteins identified as having a region of
high structural similarity to an HIV protein are referred
to as "HIV-similar." Next, we identify known interactions
for these HIV-similar proteins, with the one or more
human proteins that they interact with referred to as "tar-
gets." We then assume that HIV proteins have the same
interactions as their human, HIV-similar counterparts,
allowing HIV to plug into the host cell protein network at
these points (Figure 1). Using data from recent RNAi
screens and cellular co-localization information, we
refine this interaction map so as to enrich for those inter-
actions having the greatest potential to be correct based
on the available information. Evaluation of these predic-
tions shows a statistically significant enrichment of
known interactions as well as numerous novel interac-
tions with potential functional relevance. These predic-
tions provide an additional tool for further investigations
into the lifecycle of HIV-1 and identification of potential
clinical targets.
Results and Discussion
Identification of HIV-similar human proteins
To construct a map of interactions between HIV-1 and
human proteins, we established a multi-step protocol that
begins with the identification of human proteins having
significant structural similarity to HIV-1 proteins (Figure
2). We used the Dali Database [16,17], which contains 3D
structure comparisons for all protein structures in the
Protein Data Bank (PDB); all publicly available crystal
structures for HIV-1 and H. Sapiens are contained within
PDB. While the crystal structure for many human pro-
teins is unknown, most HIV-1 proteins have been at least
partially resolved. Specifically, crystal structures exist for
PR, RT, IN, CA, MA, NC, Gag p2, gp120, gp41, Nef, Tat,
Vpr, and Vpu (Table 1). The three enzymes encoded by
HIV-1, protease (PR), reverse transcriptase (RT), and
integrase (IN) are the best characterized structurally, hav-
ing at least 25 structures each in the PDB, with PR having
over 300. CA, gp41, and gp120 are also fairly well studied.
We note, however, that many of these structures repre-
sent only part of the full-length protein. HIV-1 proteins
having regions of high similarity to at least one human
protein include: gp41, gp120, CA, MA, Gag p2, PR, IN,
RT, and Vpr (Additional File 1). Therefore, predictions
were made for nearly every HIV-1 protein that has a pub-
lished structure.
Figure 1 Diagram of approach. HIV-1 proteins showing structural 
similarity to one or more human proteins are first identified. Interac-
tions for these "HIV-similar" proteins with other human proteins are 
then identified. Following appropriate filtering, this methodology pre-
dicts the existence of a physical interaction between the HIV protein 
and the human "target" protein(s).Doolittle and Gomez Virology Journal 2010, 7:82
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Selected examples of structural similarities between the
HIV-1 proteins IN, RT, and gp41 and human proteins
determined by Dali are shown in Figure 3. The structural
similarities frequently involve only part of each protein.
However, since in most cases the precise location of pro-
tein interaction sites is not known, we used the entire
structure in our investigation.
Protein interaction prediction
Upon obtaining the knowledge of which specific HIV-1
and human proteins have high structural similarity, we
extract all known interactions for human proteins from
the Human Protein Reference Database, which contains
over 37,000 documented protein interactions [18]. Again,
the central premise is that given a network of protein
interactions, proteins with similar structures or substruc-
tures will tend to have similar interaction partners. Thus,
our hypothesis is that HIV-1 proteins having similar
structure to one or more human proteins are also likely to
participate in the same set of protein interactions (Figure
1). Under these assumptions, we directly mapped HIV-1
proteins to their high-similarity matches within this net-
work. 
To reduce the number of predictions and provide an
additional line of functional evidence for interactions and
their possible biological relevance, we filtered these
results using two types of datasets on host proteins
involved in HIV-1 infection; collectively referred to as
"Literature Filters" hereon. The first type represents host
proteins that have been shown to impair HIV-1 infection
or replication when knocked down by siRNA or shRNA.
Three genome-scale siRNA screens have been conducted
in HeLa or 293T cells [19-21]. A fourth study with a simi-
lar goal was conducted using shRNA in Jurkat T-cells, a
more realistic model of HIV-1 infection [22]. Each of the
four screens found over 250 host proteins involved in
HIV-1 infection. Remarkably, very little overlap exists
between these studies, perhaps due to differences in
methods, including the cell lines and stages of the HIV-1
life cycle investigated.
The second type of data used to filter predictions is lit-
erature data identifying human proteins present in the
HIV-1 virion. During budding, host proteins from both
the cell surface and the cytoplasm, including some
involved in the cytoskeleton, signal transduction, metab-
olism, and chaperones, may be incorporated into the
virion [23]. While some of these proteins may be taken up
by the budding virus simply by chance, others are known
to be specifically incorporated into the virion and may
play key roles in viral life cycle or pathogenesis. For exam-
ple, TSG101 may be incorporated due to its interaction
with Gag, and facilitates budding [23,24].
We considered only predicted interactions where the
target protein was observed in at least one of the previ-
ously described Literature Filters. The resulting predicted
HIV-human interaction network consists of 2143 interac-
tions, considering all unique combinations of Uniprot
accessions for an HIV-1 protein and a predicted human
interactor (Figure 2). Of the predictions that were made,
62 were verified as true interactions based on data from
Figure 2 Structural prediction workflow. Structural similarities from Dali and known interactions between human proteins from HPRD are used to 
predict interactions between HIV-1 and human proteins. These predictions are filtered based on functional information from previous studies to make 
a first set of predictions. This set is further filtered using GO cellular component terms to yield a final prediction set including fewer predictions with 
higher confidence. Numbers represent the number of interactions, or structural similarities in the case of Dali, at each stage of the process.Doolittle and Gomez Virology Journal 2010, 7:82
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two databases of known host-pathogen interactions,
HHPID and PIG (Additional Files 2 and 3). There were
347 human proteins predicted to have structural similari-
ties with an HIV-1 protein and the predictions implicate a
total of 406 unique human proteins as potentially inter-
acting with HIV-1 (Table 2).
We visually examined some of the structural similari-
ties that led to predictions that were already known.
SMN2 is structurally similar to integrase (IN) (Figure 3A,
Additional File 1) and both SMN2 and IN are known to
interact with SIP1 (Gemin2) [18,25]. SIP1, part of the
large SMN complex involved in the assembly of snRNPs,
may also be part of the pre-integration complex during
HIV-1 infection and may aid viral reverse transcription
[26]. There are also several predicted interactions
between IN and host proteins that interact with SMN2
that have not yet been tested (Additional File 1). The
structural similarities shown in Figure 3B-D also led to
predictions of known interactions, even though only part
of the proteins are structurally similar.
Protein co-localization
To further narrow the list of likely interactions, we
refined these results by requiring both the HIV-1 protein
and the target human protein to be present in the same
location within the cell, based on GO cellular component
(CC) annotation. The refined set of predictions is shown
in Figure 4. Including this filtering step reduced the num-
ber of interaction predictions to 502, involving 189 HIV-
similar proteins having 137 known different binding part-
ners. There are 31 predictions corresponding to already
known HIV-human interactions (Table 2, Additional File
4). Using the criterion that interacting proteins must have
some evidence of co-localization not only reduced the
size of the predicted interactome, but also increased the
percentage of true positive predictions from ~3% true
positives before filtering to over 6% after filtering (Table
2).
Taking localization into account, gp41 has many more
predicted interactors than any other HIV-1 protein. This
is most likely due to the relatively large number of GO
Table 1: HIV-1 protein structures
Representation of HIV-1 proteins
HIV-1 protein PDB chains in Dali PDB structures in Dali
capsid 52 25
gp120 24 20
gp41 24 17
integrase 51 26
matrix 17 12
nef 5 3
nucleocapsid 3 3
p2 1 1
protease 604 304
reverse transcriptase 176 85
tat 3 3
vpr 1 1
vpu 1 1
The number of structures representing each HIV-1 protein in Dali.Doolittle and Gomez Virology Journal 2010, 7:82
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cellular component terms that were annotated to gp41
and also relevant to the host cell. Since gp41 is known to
be found in more parts of the cell than other HIV-1 pro-
teins, a larger number of human proteins were able to
meet the co-localization criterion.
The interaction predictions made by this method are
specific for structures, and we note that different struc-
tures for a single protein may lead to different predictions
about its interactions. Therefore, some information is lost
if predictions are described at a gene level. Nevertheless,
it may be of interest to consider interactions on a gene
basis (See Additional File 5 for the mapping of HIV-1
IDs). When counted according to the HIV-1 protein node
names and human target Entrez Gene IDs, we made 883
interaction predictions, 56 of which were true positives
according to HHPID and PIG. Following CC filtering, we
had 22 true positive predictions among 265 total predic-
tions (~10% of known true positives). While these results
tend to suggest higher rates of predictive accuracy when
using our method, we report our more conservative Uni-
prot-based accuracy values as our best estimates.
Properties of human proteins predicted to interact with 
HIV-1
Using the CC-filtered predictions, we next examined the
function of human proteins predicted to interact with
HIV-1 during infection. In this instance, we sought bio-
logical process and molecular function GO terms that
were enriched among these target proteins. Examining
the function of human proteins found in our filtered list
of interactions, significant enrichment is observed in the
processes of protein transport, nucleic acid transport, sig-
Figure 3 Selected Structural Similarities. Structures of HIV-1 and 
human proteins aligned using Dali. (A) IN (1ex4A) aligned with SMN2 
(1g5vA) [51,52]. (B) NXF1 (1ft8E) aligned with RT (1tl3A) [53,54]. (C) gp41 
(2cmrA) aligned with PTK2 (1k04A). [55,56]. (D) RT (1lwcA) aligned with 
PLEC1 (1mb8A) [57,58]. HIV-1 proteins are in blue, human proteins are 
in yellow.
Table 2: Summary of Predicted Interactions
Prediction Results Summary
Before CC filter After CC filter
Structure Nodes 11 10
HIV-1 Uniprot 49 33
Similar Human Proteins 347 189
Predicted Human Binding Partners 406 137
True Positives 62 31
Total Predictions 2143 502
Percent True Positive 2.89% 6.18%
The number of proteins found as well as interaction predictions made by the method are shown. HIV-1 Structure Nodes refers to the number 
of HIV-1 proteins represented in Dali, while HIV-1 Uniprot refers to the number of HIV-1 Uniprot accessions present in the predictions. Human 
proteins and predicted interactions are counted by unique Uniprot accessions.Doolittle and Gomez Virology Journal 2010, 7:82
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Figure 4 Predicted interaction network after cellular component filtering. In addition to the prediction of a physical interaction, the human pro-
teins included in this prediction set are known to have a role in HIV-1 infection or replication as supported by 1) evidence of incorporation into the 
HIV-1 virion or 2) their reduced expression is known to prevent HIV-1 infection (node line color corresponds to source). Predictions were filtered to 
contain only those pairs of proteins that share at least one Gene Ontology cellular component term. Red lines represent predicted interactions that 
are already known to occur.Doolittle and Gomez Virology Journal 2010, 7:82
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naling, cell death, and post-translational modifications
(Figure 5A); all of these processes are known to be manip-
ulated or altered by HIV-1 during infection. During the
course of the HIV-1 lifecycle, viral protein and nucleic
acids must be transported from one part of the cell to
another to ensure viral replication. The Pre-Initiation
Complex (PIC), consisting of a number of viral and host
proteins and the viral genome, must be transported from
the site of viral entry to the nucleus for integration of the
provirus. In addition, Env and Vpr are known to play both
pro- and anti-apoptotic roles by manipulating host sig-
naling. For instance, there is evidence that HIV-1 may
inhibit apoptosis in infected cells to prevent the cell from
dying before the virus can replicate and assemble. On the
other hand, HIV-1 can also promote apoptosis of
immune cells using several pathways; indeed, the pro-
gressive destruction of CD4+ T cells is a well known indi-
cation of AIDS [27].
Interestingly, all of the significantly enriched molecular
function GO terms relate to GTP binding or hydrolysis
(Figure 5B). GTPases are involved in a number of host
processes that HIV-1 may take advantage of, including
nuclear transport and cytoskeletal rearrangements that
facilitate viral entry and cellular motility. Statins, a class
of drugs that lowers cholesterol levels in the blood, have
also been shown to inhibit HIV-1 infection by preventing
viral fusion with the cell membrane through a mecha-
nism that involves inhibition of Rho GTPases [28]. In
addition, p115-RhoGEF inhibits HIV-1 gene expression
through the activation of RhoA [29]. Furthermore, both
Rho and Rho kinase play a role in the cellular motility that
allows HIV-1 infected monocytes to cross the blood-
brain barrier to cause HIV-1 encephalitis [30].
Actin microfilaments of the cytoskeleton are regulated
by actin-binding proteins as well as Rho family small
GTPases including Rho, Rac, and Cdc42 [31]. IN, RT, and
gp41 were all predicted to interact with RhoA, Rac1, and
Cdc42 (Figure 4). We found that gp41 has regions of
structural similarity with many cytoskeleton related pro-
teins, including erythrocytic spectrin alpha (SPTA1),
erythrocytic spectrin beta (SPTB), alpha actinin 4
(ACTN4), alpha actinin 2 (ACTN2), moesin (MSN), Rho-
associated coiled-coil containing protein kinase 1
(ROCK1), and arfaptin 2 (ARFIP2). IN resembles NCK
adaptor proteins 1 and 2 (NCK1/2), dynactin 1 (DCTN1),
and RAS GTPase activating protein 1 (RASA1), among
others (Additional File 4). The cytoskeleton has been sug-
gested to be manipulated by HIV-1 during virion fusion,
assembly, and budding [31]. HIV-1 movement through
the cell can be blocked by drugs that cause depolymeriza-
tion of microtubules and actin filaments. Actin has also
been found within HIV-1 virions, and is incorporated
through binding with NC [32]. Thus, our predictions may
aid further investigation into the ways in which HIV-1
manipulates the cytoskeleton.
By integrating a variety of high-quality functional data
sets in the Literature Filter, we created a smaller interac-
tion map that has the potential to provide a physical
interaction context for a number of experimental find-
ings. As an example, retroviral budding is known to
involve members of the endosomal sorting complexes
(ESCRTs). The ESCRT complexes normally induce the
formation of multivesicular bodies in the endosome, but
can be recruited to the plasma membrane by Gag to aid
in viral budding. Many members of the ESCRT machin-
ery appear in our results, including VPS4A, STAM2,
EEA1, RAB5A, and TSG101 [1]. Early endosomal autoan-
tigen 1 (EEA1) is recruited to early endosomes by Rab5
and phosphatidylinositol 3-phosphate [33]. Our results
show that gp41 and Gag p2 may interact with RAB5A,
since they are structurally similar to EEA1 (Figure 4,
Additional Files 1 and 3). EEA1 contains a FYVE domain
and colocalizes with human hepatocyte growth factor-
regulated tyrosine kinase substrate (Hrs) protein [33,34].
Gp41 is also known to interact with AP1G2, an important
component of clathrin-coated vesicles. AP1G2 interacts
with RAB5A and provides further support for the possi-
bility that gp41 interacts physically with RAB5A, but
through a potentially different structural motif [35]. The
Gag p6 protein is a known mimic of Hrs, and like Hrs can
recruit TSG101, which is required for the formation mul-
tivesicular bodies (MVBs) and viral budding [36]. Gag p2,
as well as a model of gp41, show structural similarity to
the human protein CEP55, which recruits TSG101 to the
thin membrane that separates the daughter cells, where it
is needed for the final separation of two cells [37]. Our
results suggest that gp41, IN, and the p2 region of Gag
may all be able to interact with TSG101 (Figure 4, Addi-
tional File 4). Overall, interaction predictions are sup-
ported by a variety of studies implicating host
mechanisms of vesicle formation in HIV-1 infection.
Additional method assessment
T o  f u r t h e r  a s s e s s  o u r  p r e d i c t i o n s,  w e  d e t e r m i n ed  h o w
many known interactions, curated within either HHPID
or PIG, could have possibly been predicted using our
method and the available data. First, in order for our
approach to suggest a possible HIV-human interaction,
the HIV protein must be represented among the crystal
structures from PDB that are included in the Dali Data-
base. In addition, any host factors predicted to interact
with HIV-1 must have at least 1 known interaction with
another human protein, and to be considered further,
each of these must also have representative structures
within Dali. Finally, in this work we included only those
proteins that have been implicated in playing a role inDoolittle and Gomez Virology Journal 2010, 7:82
http://www.virologyj.com/content/7/1/82
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Figure 5 Significantly enriched Gene Ontology terms in the Human-HIV-1 interaction network. GO Terms removed at least 5 levels from the 
root for (A) Biological process and (B) Molecular function. Bonferroni corrected p-values (α = 0.01) were -log10 transformed.
A
B
positive regulation of cellular process
peptidyl amino acid modification
nuclear import
negative regulation of programmed cell death
protein import into nucleus
negative regulation of apoptosis
peptidyl tyrosine modification
peptidyl tyrosine phosphorylation
protein targeting
mRNA transport
small GTPase mediated signal transduction
nucleobase, nucleoside, nucleotide and nucleic acid transport
establishment of RNA localization
RNA transport
nucleic acid transport
negative regulation of cellular process
nuclear transport
nucleocytoplasmic transport
intracellular transport
intracellular protein transport
regulation of programmed cell death
regulation of apoptosis
cell development
programmed cell death
apoptosis
signal transduction
intracellular signaling cascade
protein transport
establishment of protein localization
Biological Process
 log(Bonferroni)
02468
nucleoside triphosphatase activity
guanyl nucleotide binding
guanyl ribonucleotide binding
GTP binding
GTPase activity
Molecular Function
 log(Bonferroni)
01234567Doolittle and Gomez Virology Journal 2010, 7:82
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HIV-1 infection through RNAi studies or studies of the
protein composition of the virion. Since we removed any
human target proteins that did not pass the Literature Fil-
ter, we did not make predictions for human proteins not
mentioned in previous studies.
A total of 319 known host-pathogen interactions satis-
fied these criteria. Sixty-two of these interactions (~19%)
were predicted by our methodology, and are the set of
predictions considered to be true positives (shown in
Table 3). We also investigated how many of these possible
interactions could have been found after using the cellu-
lar component filter, and determined that only 166
known interactions met the additional criterion of being
annotated to the same cellular component. Within this
set, our method found 31 of these (~19%). This result
suggests that while the number of interactions considered
was decreased by considering cellular localization, the
number of true positive predictions did not improve.
Obviously, without experimental validation we cannot
determine whether the CC filter led to better prediction
accuracy within the set of predictions not previously
described in the literature or elsewhere. It is clear, how-
ever, that GO cellular component annotation is incom-
plete and the lack of shared annotation does not
completely exclude the possibility that two proteins may
interact; inclusion of the CC filter did double the percent-
age of true positives predicted when considering
unknown potential interactions as well as those previ-
ously known.
As an additional form of assessment, we investigated
how often we could expect to find previously known
interactions by chance alone. Starting from proteins in
HPRD, we found that ~0.17% of the known interactions
could be found at random (see Methods). Cellular Com-
ponent filtering of these random predictions gave a slight
improvement with an average of 0.29% true positives
(Table 4). Using only HPRD human target proteins that
pass the Literature Filter increased the true positive accu-
racy of random predictions to 0.57%. This value can be
compared to the value of 2.89% indicated in Table 2.
When these random predictions were also run through
the CC Filter, an average of 1.03% true positives were
found (Table 4) versus a 6.18% when using our method
(Table 2). Thus the Literature Filter and the CC Filter
improved the accuracy of the true positive predictions
individually, and to an even greater extent when com-
Table 3: Method evaluation
Database Evaluation
Before CC filter After CC filter
Predicted True Positives 62 31
Possible True Interactions 319 166
Percent Found 19.44% 18.67%
Comparison of the number of known interactions predicted to the number of known interactions that could have theoretically been found 
using the available data.
Table 4: Accuracy of Random Predictions
Random Predictions
Filtering Mean Accuracy Standard Error
None 0.166% 2.79e-3%
CC 0.286% 6.09e-3%
Lit 0.567% 4.84e-3%
Lit CC 1.030% 1.07e-2%
Shown are the mean percent of true positives and standard error of the mean for random predictions without any filtering (None), CC 
Filtering alone (CC), Literature Filtering alone (Lit), and both Literature and CC Filtering (Lit CC).Doolittle and Gomez Virology Journal 2010, 7:82
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bined. However, even with both filters, at best ~1% of the
random predictions were found to be true positives, fur-
ther indicating that incorporating structural information
generates predictions with enhanced accuracy and bio-
logical validity.
Overlap with other studies
We also compared our predictions to those made by two
previous computational studies predicting protein-pro-
tien interactions between HIV-1 and humans, namely the
studies by Evans et al. and Tastan et al. [9,10]. Since these
investigations reported their results in terms of genes, we
compared them to our predictions as counted by gene, to
find interactions predicted by multiple methods (Figure
6). We did not find a high degree of overlap between the
predictions made by the various studies. This was not
surprising, as even large-scale experimental protein inter-
action studies typically show little overlap in their results.
Furthermore, the methodology used to generate the pre-
dictions differed significantly between studies. Our
method used structural similarity to predict interactions,
whereas Evans et al. looked for the presence of sequence
motifs and counter domains and Tastan et al. integrated a
variety of information, including information from GO,
properties of the human interactome, and sequence
motifs [9,10]. There are a greater total number of shared
predictions between Evans et al. and Tastan et al. than
between our results and either one of the others. This
may be due to the fact that Tastan et al. incoportated
Eukaryotic Linear Motifs (ELMs) and binding domains,
the key predictor used in the work of Evans et al., as one
of the features used in their prediction method. In addi-
tion, the other two studies had a larger number of predic-
tions overall. Approximately 7% of the predictions by
Tastan et al. were found in the study by Evans et al.
Approximately 5% of our predictions (Literature and CC
filtered) were found by Evans et al. and 10% were shared
with Tastan et al.
There were a few predictions that were shared between
all methods. For our results before CC filtering, we found
that there were 9 interactions predicted by all three meth-
ods (F igure 6A). Of these, four were determined to be
true positives in our results: RT and MAPK1, gp41 and
LCK, gp41 and PTPRC, and IN and PRKCH. The other
five interactions (RT and PIN1, p2 and MAPK1, p2 and
YWHAZ, gp41 and PLK1, gp41 and MAPK1, gp41 and
CLTC, IN and XPO1, and IN and YWHAZ) are not
known to occur, and may be good candidates for further
investigation since they were predicted by three diverse
methods. After we filtered our predictions by shared cel-
lular components, three predictions were still common
between all three studies, gp41 and LCK, gp41 and PLK1,
IN and XPO1, one of which is a known interaction (Fig-
ure 6B). In summary, although few predictions were
shared by all three studies, a large proportion of them are
already known to occur, suggesting that the others may be
worthy of high priority in future experimental efforts.
Conclusions
We have generated a map of potential protein-protein
interactions between HIV-1 and its human host. The
computational methodology used to create this map is
based on the assumption that proteins with similar struc-
tures will share similar interaction partners. Thus HIV-1
proteins having a structure similar to one or more human
proteins may potentially "plug in" to the host protein
interactome at these points; providing the interface
through which manipulation of downstream host pro-
cesses can occur. From previous literature, many human
proteins are known to play some role in HIV-1 infection.
However, in most cases the nature of this role is
unknown. Here, we provide specific predictions of how
these human proteins may influence viral infection,
namely by interacting with certain HIV-1 proteins.
In principle, our approach is applicable to any host-
pathogen system with known protein structures. HIV-1
has a small proteome, with most of its protein structures
at least partially determined. In addition, HIV-1 also has a
large set of identified interactions that can be used for
Figure 6 Overlap with previous studies. Venn diagrams of the over-
lap between between our method and previous computational stud-
ies by Evans et al. and Tastan et al. (A) with Literature filter and (B) with 
Literature and CC filter [9,10].Doolittle and Gomez Virology Journal 2010, 7:82
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model validation. While few pathogens currently have
such rich data sets, continued progress in protein struc-
ture determination will help to remedy such deficiencies.
Identification of points of modulation between a host
and pathogen requires multiple lines of evidence. Com-
putational methods can help integrate these data, provid-
ing a promising avenue for the discovery of novel host-
pathogen interactions mediated by structural similarities
as well as enhancing our understanding of functional
relationships characterized through modern screening
methods such as siRNA. Knowledge of the protein inter-
action network between the pathogen and human will
not only further our basic understanding of pathogen
survival mechanisms, but may also provide clinical tar-
gets to combat infectious disease.
Methods
Data Sources
We used the Dali Database for structure comparisons
(downloaded in January 2009), and the Human Protein
Reference Database (HPRD), HHPID and PIG for protein
interactions (downloaded February, July and June 2009,
respectively) [16-18,25,38]. The literature sources and
various databases used each have their own system of
identifiers. PDB codes obtained from Dali were mapped
to their corresponding taxonomy and Uniprot accessions
using data from the SIFTS initiative [11,39,40]. Other
identifier mappings were carried out using DAVID Gene
ID Conversion or Uniprot ID mapping [41-43]. Network
diagrams were created in Cytoscape [44]. Images of pro-
tein structures were created in MacPyMol [45].
Determination of structural similarity between HIV-1 and 
host proteins
We used the Dali database to ascertain structural similar-
ity. Dali compares the 3D structural coordinates of two
PDB entries by alignment of alpha carbon distance matri-
ces, allowing for differences in domain order, and pro-
duces a structural similarity score [11,16,17]. The Dali
Database includes structural comparisons where proteins
from PDB90, a subset of the PDB where no two proteins
share more than 90% sequence similarity, were used as
queries against the full PDB [46]. For this study, we took
into consideration all human proteins that were listed in
the Dali database as being similar to an HIV-1 protein
(NCBI Taxonomy ID: 11676) and having a z score above
2.0, with the HIV-1 protein being either the query or the
hit. We refer to these human proteins as "HIV-similar"
proteins. No proteins of unknown structure were consid-
ered.
Interaction Prediction
We found known interactions between HIV-similar pro-
teins and target human proteins, using data from the
HPRD database, which contains literature curated inter-
actions between pairs of human proteins [18]. For each
HIV-similar protein, we predict that the target proteins,
which are known to both interact with the HIV-similar
protein and pass the Literature Filter, might also interact
with the corresponding HIV-1 protein. Therefore, inter-
actions between the HIV-similar and the human target
proteins were mapped directly to the corresponding HIV
protein.
Filtering
To reduce the number of predictions as well as add infor-
mation from functional studies, predictions were filtered
based on previous implication of the human protein's
involvement in the HIV-1 infection process. One crite-
rion was presence of the host protein in the HIV-1 virion.
Host proteins known to be incorporated into or onto
HIV-1 during budding were taken from several literature
sources [23,24,47]. The presence of host proteins in or on
HIV-1 may be a result of specific recruitment and serve a
functional role, may result from localization of the pro-
tein near the site of budding, or may simply occur by
chance. Predicted interactions between HIV-1 proteins
and human proteins that are incorporated into the HIV-1
virion were retained. In addition, any human protein that
is incorporated into the virion and is itself structurally
similar to an HIV-1 protein was also included as a possi-
ble interaction.
Another filtering criterion was the host protein's essen-
tiality for HIV-1 infection. Recently, several large-scale
experiments using siRNA or shRNA knockdowns to
identify host proteins involved in the HIV-1 life cycle
have been published [19-22]. The probe ids of the genes
implicated by Yeung et al. were mapped to their Entrez
Gene IDs using the appropriate Affymetrix annotation
file http://www.affymetrix.com/products_services/
arrays/specific/hgu133plus.affx#1_4[22]. This filter is
referred to as the "Literature Filter." Host proteins that
were implicated in at least one of these studies as having a
possible role in HIV-1 infection or replication, and which
are also known to interact with an HIV-similar protein,
were predicted to interact with an HIV-1 protein in the
final predicted network. 
To create a smaller and potentially more reliable list for
further experimental validation, we further filtered the
predictions based on shared sub-cellular localization. The
Cellular Component (CC) Filtered dataset contains inter-
action predictions where the two proteins share Gene
Ontology (GO) cellular component annotation. Pairs of
HIV-1 and human proteins predicted to interact were
only included in this dataset if both proteins were anno-
tated by DAVID as being present in the same cellular
compartment [41,42]. Pairs with only the terms "cell" and
"cell part" in common were excluded due to a large num-Doolittle and Gomez Virology Journal 2010, 7:82
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ber of such pairs and the relative lack of specificity of
these high level terms.
Validation of Predictions
Since within Dali there may be multiple PDB structures
representing the same protein, there is some redundancy
in the interaction predictions. In certain cases, multiple
PDB structures for the same HIV-1 protein were found to
be similar to multiple PDB structures for an HIV-similar
protein, leading to the same interaction predictions.
Therefore, the predictions were counted as unique pairs
of Uniprot accessions. In addition, for ease of viewing the
predicted interactome, each node representing an HIV-1
protein is labeled with the protein name while each
human protein is represented by Entrez Gene ID. To
determine the correct mapping of PBD codes to HIV-1
proteins, the molecule name associated with each PDB
chain was searched for keywords indicating the protein,
with ambiguous cases treated on an individual basis. For
example, PDB molecule names containing the word
"capsid" but not "nucleocapsid" were assigned to the node
"capsid." Furthermore, molecule names indicating poly-
proteins, such as those containing the phrase "gag-pol"
were checked individually to determine which specific
part of the polyprotein was represented by the entry. Two
PDB structures were found to represent more than one
mature HIV-1 protein: 1l6nA contains both capsid and
matrix, while 1bajA contains capsid and p2 [48,49]; these
structures are represented as "capsid, matrix" and "capsid,
p2" respectively. When counting predictions at the gene
level, we considered pairs of HIV-1 node names and
human target Entrez Gene IDs.
To determine which predictions are true positives, PIG
and HHPID entries for the predicted human interactors
were examined to see if they contained the HIV-1 protein
they were predicted to interact with [25,38]. These inter-
action databases consist of PPIs curated from the litera-
ture. HHPID uses keywords to characterize the different
types of interactions listed in this database. Since this
work attempts to predict physical interactions, only
entries with keywords representing direct interactions
were included [9]. The Uniprot accessions associated
with the HIV-1 protein PDB entry, in the case of PIG, or
the Entrez Gene ID mapped to that Uniprot accesion, in
the case of HHPID, was checked to see if it was present as
an already known interaction of the human protein.
GO Term Enrichment
The Gene Ontology (GO) provides a system of terms to
consistently describe and annotate gene products [50].
GO term enrichment was performed using the DAVID
Functional Annotation Chart tool. The GO is organized
as a tree structure, with terms becoming more specific as
distance from the root increases. Therefore, to avoid very
general and uninformative GO terms, only those that are
found at least 5 steps removed from the overall root of
GO were considered. The p-values were corrected for
multiple testing using the Bonferroni procedure and
transformed by taking the -log10 for easier visualization.
Computational evaluation
Two forms of computational validation of the method
were conducted. As it is not possible to predict all known
interactions due to lack of protein structures, as well as
other factors, we first determined the largest set of
known interactions that it is theoretically possible to pre-
dict using our approach. To do this, we first determined
the sets of all proteins that could be considered. This
includes the set of all HIV-1 proteins in Dali (HIV set),
the set of all human proteins that are represented in both
Dali and HPRD (possible HIV-similar set), and the set of
all human proteins in HPRD that are known to interact
with at least one protein in the possible HIV-similar set as
well as pass the literature filter (possible target set). Next,
every pairwise combination of proteins in the HIV set
and the possible target set was checked to see if it repre-
sented a known interaction curated in HHPID or PIG.
The resulting number of true interactions that could have
been found by the method was compared to the number
of true positives that were actually found, both before and
after filtering by cellular components.
In the second approach, actual prediction results were
compared to predictions based on randomly selected
HIV-human protein pairs. The HIV-1 proteins were cho-
sen from the 69 Uniprot accessions represented at least
once by structures in the Dali Database. For human pro-
teins, two different sets of human Uniprot proteins were
created, one containing all the proteins in HPRD, and the
other containing the subset of human proteins that also
passed the Literature Filter. The set of all human proteins
in HPRD consisted of 8582 proteins and was used to see
the accuracy of purely random predictions, while the sec-
ond set of 830 proteins was used to observe the effect of
the Literature Filter.
Since the structural similarity step was omitted, the
predictions based on a human protein being similar to an
HIV-1 protein and incorporated into the virion could not
be simulated with the random selection procedure. We
found that if we excluded this class of predictions from
our real results, the number of unique predictions made
was reduced to 2139, but all 62 true positives were still
included. Therefore, we randomly selected 2139 pairs of
HIV-1 proteins and human proteins from the entire
HPRD, and a second set of 2139 pairs of HIV-1 proteins
and Literature Filtered human proteins for evaluation.
Next, any known interactions between the randomly cho-
sen pairs were found using HHPID and PIG. Additionally,Doolittle and Gomez Virology Journal 2010, 7:82
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both the unfiltered and Literature Filtered random pre-
dictions were then subjected to the CC Filter to gauge the
improvement due to this step of the method. The CC Fil-
ter reduced the number of predictions to a variable
degree, depending on how many of the random predic-
tions were annotated with the same GO cellular compo-
nent term. The entire procedure was repeated 1000
times. The mean and standard error of the mean for each
of the four variously filtered random prediction sets was
calculated using R. The distributions of random predic-
tions after Literature Filtering were approximately nor-
mal, so one-sided single sample t-tests were performed to
determine if the method performed significantly better
than random. In addition, we performed Wilcoxon
signed-rank tests that do not make assumptions about
normality. When comparing our results to random pre-
dictions that had undergone the same filtering steps,
either the Literature Filter or both the Literature and CC
Filters, the p-values were less than 2.2e-16 for all statisti-
cal tests. In addition, even when performing the random-
ization procedure 10000 times, none of the randomly
selected interaction sets had a true positive rate higher
than that observed in our results, suggesting a p-value of
no greater than 0.0001.
To compare our predictions to those made by Evans et
al. and Tastan et al., we found the intersection of the pre-
diction sets, counted by HIV-1 protein name and human
Entrez Gene ID [9,10]. Since each study used different
names for the HIV-1 proteins, we had to map the naming
schemes to each other to find common predictions. For
example, Evans et al.'s "CA" and "GAG" and Tastan et al.'s
"gag_capsid" and "gag_pr55" were mapped to our "capsid."
Proteins for which we made no predictions, such as Rev,
were not mapped to anything in our results, but were
converted between Evans et al. and Tastan et al. to find
overlap between these two studies.
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between the HIV and human protein. This file is provided in tab-separated 
text format and may be viewed in a text editor or Excel.
Additional file 2 Interaction Predictions. Interaction predictions, before 
the CC Filter. Column descriptions: HIV PDB code- PDB code of an HIV-1 
protein in Dali, HIV node name- protein name used to represent the HIV 
protein in the interaction network, HIV-sim Human PDB code- PDB code of 
a human protein similar to the HIV protein, HIV-sim Human Gene Symbol- 
the Entrez Gene Symbol of the human protein that is similar to the HIV pro-
tein, HIV-sim Human GeneID- the Entrez GeneID of the human protein that 
is similar to the HIV protein, HIV-sim Human Uniprot- the Uniprot accession 
of the human protein that is similar to the HIV protein, Human node Gene 
Symbol- the Entrez Gene Symbol of a human protein predicted to interact 
with the HIV protein. The Gene Symbol was used to represent the human 
protein in the interaction network, Human interactor GeneID- the Entrez 
GeneID of a human protein predicted to interact with the HIV protein, 
Human interactor Uniprot - the Uniprot accession of a human protein pre-
dicted to interact with the HIV protein, Source Datasets- paper(s) with sup-
port for a role of the human protein in HIV infection, True Positive?- whether 
or not the predicted interaction is already represented in PIG or NIAID, 
Type-whether the prediction was made because the human protein is 
known to interact with an HIV-similar protein or because the human pro-
tein is HIV-similar itself and known to be incorporated into the HIV virion, 
NIAID- HIV proteins listed in NIAID as interacting with the human protein, 
PIG- HIV proteins listed in PIG as interacting with the human protein. This 
file is provided in tab-separated text format and may be viewed in a text 
editor or Excel.
Additional file 3 Full Prediction Network. HIV-1 proteins that resemble 
human proteins are predicted to interact with the known interactors of the 
mimicked protein. The human proteins included in the prediction set have 
a supported role in HIV-1 infection or replication, either because they are 
incorporated into the HIV-1 virion or their reduced expression is known to 
prevent HIV-1 infection (node line color corresponds to source). Red lines 
represent predicted interactions that are already known to occur. This is an 
image file in .png format.
Additional file 4 Interaction Predictions after CC Filter. Interaction pre-
dictions after the CC Filter. Column headers are as in Additional file 2, with 
the addition of the last column, CC in common- list of GO cellular compo-
nent terms annotated to both the HIV and human proteins. This file is pro-
vided in tab-separated text format and may be viewed in a text editor or 
Excel.
Additional file 5 HIV-1 Protein Identifiers. The PDB codes and Uniprot 
accessions that correspond to each HIV-1 protein are given. This file is pro-
vided in tab-separated text format and may be viewed in a text editor or 
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